Pediatric Neurology
Volume 43, Issue 1 , Pages 35-40 , July 2010

Ocular MECP2 Protein Expression in Patients With and Without Rett Syndrome

  • Deepali Jain, MD

      Affiliations

    • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • Kamaljeet Singh, MD

      Affiliations

    • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • Sankar Chirumamilla, MD

      Affiliations

    • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • Genila M. Bibat, MD

      Affiliations

    • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Hugo W. Moser Research Institute, Kennedy Krieger Institute, Baltimore, Maryland
    • ,
  • Mary E. Blue, PhD

      Affiliations

    • Hugo W. Moser Research Institute, Kennedy Krieger Institute, Baltimore, Maryland
    • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • SakkuBai R. Naidu, MD

      Affiliations

    • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Hugo W. Moser Research Institute, Kennedy Krieger Institute, Baltimore, Maryland
    • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Corresponding Author InformationCommunications should be addressed to: Dr. Naidu; Kennedy Krieger Institute; 707 N. Broadway; Baltimore, MD 21205.
    • ,
  • Charles G. Eberhart, MD, PhD

      Affiliations

    • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Received 14 August 2009 ,Accepted 22 February 2010.

References 

  1. Shahbazian MD, Antalffy B, Armstrong DL, et al. Insight into Rett syndrome: MECP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet. 2002;11:115–124
  2. Trevathan E, Naidu S. The clinical recognition and differential diagnosis of Rett syndrome. J Child Neurol. 1988;3;Suppl:S6-16
  3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185–188
  4. International Rett Syndrome Foundation (IRSF). RettBASE: IRSF MECP2 Variation Database [Internet]. Available at: http://MECP2.chw.edu.au. Accessed June, 2009.
  5. Chahrour M, Jung SY, Shaw C, et al. MECP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;320:1224–1229
  6. Meehan RR, Lewis JD, Bird AP. Characterization of MECP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 1992;20:5085–5092
  7. Balmer D, Goldstine J, Rao YM, LaSalle JM. Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J Mol Med. 2003;81:61–68
  8. Armstrong DD, Deguchi K, Antallfy B. Survey of MECP2 in the Rett syndrome and the non-Rett syndrome brain. J Child Neurol. 2003;18:683–687
  9. Cassel S, Revel MO, Kelche C, Zwiller J. Expression of the methyl-CpG-binding protein MECP2 in rat brain: an ontogenetic study. Neurobiol Dis. 2004;15:206–211
  10. Maezawa I, Swanberg S, Harvey D, LaSalle JM, Jin LW. Rett syndrome astrocytes are abnormal and spread MECP2 deficiency through gap junctions. J Neurosci. 2009;29:5051–5061
  11. Ballas N, Lioy DT, Grunseich C, Mandel G. Non-cell autonomous influence of MECP2-deficient glia on neuronal dendritic morphology. Nat Neurosci. 2009;12:311–317
  12. Saunders KJ, McCulloch DL, Kerr AM. Visual function in Rett syndrome. Dev Med Child Neurol. 1995;37:496–504
  13. Kalmanchey R. Evoked potentials in the Rett syndrome. Brain Dev. 1990;12:73–76
  14. Glaze DG. Neurophysiology of Rett syndrome. J Child Neurol. 2005;20:740–746
  15. Carter JC, Lanham DC, Pham D, Bibat G, Naidu S, Kaufmann WE. Selective cerebral volume reduction in Rett syndrome: a multiple-approach MR imaging study. AJNR Am J Neuroradiol. 2008;29:436–441
  16. Armstrong DD. Rett syndrome: neuropathology review 2000. Brain Dev. 2001;23(Suppl. 1):S72–S76
  17. Hagberg B, Witt-Engerström I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet Suppl. 1986;1:47–59
  18. Renieri A, Meloni I, Longo I, et al. Rett syndrome: the complex nature of a monogenic disease. J Mol Med. 2003;81:346–354
  19. Naidu S, Bibat G, Kratz L, et al. Clinical variability in Rett syndrome. J Child Neurol. 2003;18:662–668
  20. Hoffbuhr KC, Moses LM, Jerdonek MA, Naidu S, Hoffman EP. Associations between MECP2 mutations, X-chromosome inactivation, and phenotype. Ment Retard Dev Disabil Res Rev. 2002;8:99–105
  21. Schollen E, Smeets E, Deflem E, Fryns JP, Matthijs G. Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: implications for routine diagnosis of Rett syndrome. Hum Mutat. 2003;22:116–120
  22. Laccone F, Jünemann I, Whatley S, et al. Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome [Erratum in: Hum Mutat 2004;23:395]. Hum Mutat. 2004;23:234–244
  23. Mnatzakanian GN, Lohi H, Munteanu I, et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome [Erratum in: Nat Genet 2004;36:540]. Nat Genet. 2004;36:339–341
  24. Hoffbuhr K, Devaney JM, LaFleur B, et al. MECP2 mutations in children with and without the phenotype of Rett syndrome. Neurology. 2001;56:1486–1495
  25. Ballestar E, Yusufzai TM, Wolffe AP. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MECP2 on selectivity for association with methylated DNA. Biochemistry. 2000;39:7100–7106
  26. Armstrong DD. The neuropathology of Rett syndrome. Brain Dev. 1992;14:Suppl:S89-98
  27. Naidu S. Rett syndrome: a disorder affecting early brain growth. Ann Neurol. 1997;42:3–10
  28. Armstrong DD, Dunn JK, Schultz RJ, Herbert DA, Glaze DG, Motil KJ. Organ growth in Rett syndrome: a postmortem examination analysis. Pediatr Neurol. 1999;20:125–129
  29. Armstrong D, Dunn JK, Antalffy B, Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol. 1995;54:195–201
  30. Armstrong DD, Dunn K, Antalffy B. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol. 1998;57:1013–1017
  31. Mahmood A, Bibat G, Zhan AL, et al. White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations. AJNR Am J Neuroradiol. 2010;31:295–299
  32. Cohen DR, Matarazzo V, Palmer AM, et al. Expression of MECP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci. 2003;22:417–429
  33. Armstrong DD. Neuropathology of Rett syndrome. Ment Retard Dev Disabil Res Rev. 2002;8:72–76
  34. Akbarian S, Chen RZ, Gribnau J, et al. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis. 2001;8:784–791
  35. Johnston MV, Blue ME, Naidu S. Rett syndrome and neuronal development. J Child Neurol. 2005;20:759–763
  36. Baccus SA, Olveczky BP, Manu M, Meister M. A retinal circuit that computes object motion. J Neurosci. 2008;28:6807–6817

PII: S0887-8994(10)00099-8

doi: 10.1016/j.pediatrneurol.2010.02.018

Pediatric Neurology
Volume 43, Issue 1 , Pages 35-40 , July 2010

Article Tools

* Image Usage & Resolution